Lentigo maligna (or LM) is a type of skin cancer that affects the pigmented cells in the outer layer of the skin. It usually appears in areas of the skin that have been exposed to ultraviolet rays from sunlight, such as the face, ears, and arms. LM is considered an early stage of melanoma, and if left untreated can lead to other more serious conditions. In this article, we will discuss all aspects of Lentigo maligna: what it is, its symptoms and treatment options. We will also explore why it’s so important to catch it early and how to protect yourself from getting it in the first place.
Lentigo maligna is a type of skin cancer that most often affects people over the age of 50. It is more common in women than men. The cancer develops slowly, over months or years, and usually begins as a flat, brown or black spot on the skin.
The spot may be small at first, but it can grow larger and darker over time. Lentigo maligna is most commonly found on the face, especially on the forehead, temple, cheek, or lip. It can also occur on other parts of the body that get a lot of sun exposure, such as the arms, chest, and legs.
A flat, brown or black Spot on the skin that gradually gets larger and darker
itching
A burning sensation
tenderness
crusting
bleeding
Lentigo maligna is usually diagnosed with a biopsy, which involves taking a small sample of tissue from the affected area for examination under a microscope. Treatment options for lentigo maligna include topical chemotherapy, radiation therapy, surgery, or a combination of these treatments.
Lentigo maligna is a form of melanoma, the deadliest type of skin cancer. It is most often found on the face, head, or neck. It can also occur on the arms and legs. The main symptom of lentigo maligna is a dark brown or black discoloration of the skin. The discoloration may be irregular in shape and size. It may also be accompanied by itching, burning, or bleeding. If you have any of these symptoms.Early diagnosis and treatment are critical to preventing the spread of this cancer.
There are a few different treatment options available for lentigo maligna. These include surgical removal, radiation therapy, and topical chemotherapy.
Surgical removal is the most common treatment option and involves removing the affected skin with a scalpel. This is usually done as an outpatient procedure and has a high success rate.
Radiation therapy uses high-energy waves to destroy cancer cells. It can be used as a primary treatment or in combination with surgery. Topical chemotherapy uses drugs that are applied to the skin to kill cancer cells. This option is often used when surgery is not an option or the cancer has spread to other parts of the body.
Lentigo maligna is a type of skin cancer that tends to appear on areas of the body exposed to sunlight over long periods. Although it can be difficult to detect, knowing the signs and symptoms of this condition is important for early diagnosis and treatment. If you have any concerns about your skin or believe you may be experiencing any signs or symptoms of lentigo maligna, make an appointment with a dermatologist as soon as possible for further evaluation.
Read more such content on @ Hidoc Dr | Medical Learning App for Doctors
1.
Next Day Mood Is Affected by Ability to Recover From Work.
2.
Enhanced CAR T cell therapy offers new strategy for lymphoma
3.
With the use of a novel sequencing technique, pediatric bone marrow transplant mortality can be predicted by analyzing lung microbiomes.
4.
Decrease seen in in situ breast cancer since 2009
5.
Scientists hail the cervical cancer treatment as the most remarkable breakthrough in 20 years.
1.
Discovering the Benefits of TNK: A Comprehensive Blog Article
2.
Rare Malignant Ovarian Tumors: A Comprehensive Review for Clinicians
3.
Revolutionizing Cancer Treatment with Darzalex: How an Innovative Drug is Transforming Lives
4.
Personalized Cancer Vaccines: The Next Frontier in Precision Oncology
5.
Precision Medicine and Genomics: Revolutionizing Healthcare Through Personalized Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
2.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part II
3.
Managing ALK+ NSCLC while Ensuring Long-Term Safety of the Patients
4.
Dissecting Molecular differences between EGFR Exon 19 deletion and Exon 21 L858R Mutations
5.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation